Symposia: Hemophilia A and B: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Maternal Health, Research, Bleeding disorders, Bleeding and Clotting, Adult, Clinical trials, Hemophilia, Clinical Practice (Health Services and Quality), Translational Research, Epidemiology, Clinical Research, Drug-drug interactions, Pediatric, Diversity, Equity, and Inclusion (DEI), Diseases, Real-world evidence, Treatment Considerations, Pregnant, Adverse Events, Study Population, Human, Maternal Health
Type: Oral
Hematology Disease Topics & Pathways:
Maternal Health, Research, Bleeding disorders, Bleeding and Clotting, Adult, Clinical trials, Hemophilia, Clinical Practice (Health Services and Quality), Translational Research, Epidemiology, Clinical Research, Drug-drug interactions, Pediatric, Diversity, Equity, and Inclusion (DEI), Diseases, Real-world evidence, Treatment Considerations, Pregnant, Adverse Events, Study Population, Human, Maternal Health
Saturday, December 7, 2024: 12:00 PM-1:30 PM
Room 29
(San Diego Convention Center)
Moderators:
Ruben Rhoades, MD, MS, Thomas Jefferson University
and
Sanjay Ahuja, MD, Indiana Hemophilia and Thrombosis Center, Inc.
Disclosures:
Rhoades: Novartis: Consultancy; Spark Therapeutics: Research Funding; Veralox Therapeutics: Research Funding. Ahuja: Sanofi Genzyme: Honoraria, Membership on an entity's Board of Directors or advisory committees; Genentech: Honoraria, Membership on an entity's Board of Directors or advisory committees; BioMarin: Honoraria, Membership on an entity's Board of Directors or advisory committees; CSL Behring: Honoraria, Membership on an entity's Board of Directors or advisory committees; XaTek: Membership on an entity's Board of Directors or advisory committees, Research Funding; Case Western Reserve University: Patents & Royalties: Patent for US 11,408,844 issued; US FDA: Honoraria, Other: Member of the Blood Products Advisory Committee; Governor’s Office, State of Ohio: Other: Membership on Rare Disease Advisory Council for the State of Ohio.
This session will explore how novel therapies may be used in clinical practice and will include data supporting pharmacokinetic based treatment and alternative dosing regimens as well as the use of these therapies in special populations
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH